関連する実験動画
カポシのサルコマ (Kapossi's sarcoma) とは カポシの肉腫 (Kapossi's sarcoma) とは カポシの肉腫 (Kaposi's sarcoma) とは
Cornelus J G Sanders1, Marijke R Canninga-van Dijk, Jan C Borleffs
1Department of Dermatology/Allergology, University Medical Center, Heidelberglaan 100, 3584CX Utrecht, Netherlands. c.sanders@azu.nl
Lancet (London, England)
|October 27, 2004
まとめ
No abstract available in PubMed .
関連する概念動画
こちらも読む
関連記事
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
並び替え
Same author
Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease.
Blood·2020
Same author
Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.
International journal of radiation oncology, biology, physics·2017
Same author
Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides.
JAMA dermatology·2016
Same author
Drug rash with eosinophilia and systemic symptoms caused by the dietary supplement diindolylmethane.
The journal of allergy and clinical immunology. In practice·2015
Same author
Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.
Molecular cell·2010
Same author
[Burn wounds in neonates caused by hot warming bottles].
Nederlands tijdschrift voor geneeskunde·2009
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026